Pancreatic Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Pancreatic Cancer, including details on symptoms, causes, treatment, information.

Volume 2 (2005), Issue 4 (April)

1. Nucleosomes in pancreatic cancer patients during radiochemotherapy.
   Tumour Biol, 26(1): 44-9. [Abstract] [Full-text]
2. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells.
   Cancer Res, 65(7): 2899-905. [Abstract] [Full-text]
3. Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases.
   Cancer Res, 65(7): 2861-71. [Abstract] [Full-text]
4. Broad-spectrum G protein-coupled receptor antagonist, [D-Arg1,D-Trp5,7,9,Leu11]SP: a dual inhibitor of growth and angiogenesis in pancreatic cancer.
   Cancer Res, 65(7): 2738-45. [Abstract] [Full-text]
5. Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels.
   Cancer Res, 65(7): 2712-21. [Abstract] [Full-text]
6. Circulating levels of angiogenic cytokines can predict tumour progression and prognosis in neuroendocrine carcinomas.
   Clin Endocrinol (Oxf), 62(4): 434-43. [Abstract] [Full-text]
7. Dietary patterns and pancreatic cancer risk in men and women.
   J Natl Cancer Inst, 97(7): 518-24. [Abstract] [Full-text]
8. Pharmacokinetics of the antineoplastic drug mitomycin C in regional chemotherapy using the aortic stop flow technique in advanced pancreatic carcinoma.
   Chemotherapy, 51(1): 1-8. [Abstract] [Full-text]
9. Pancreatic carcinoma versus chronic focal pancreatitis: contrast-enhanced power Doppler ultrasonography findings.
   Abdom Imaging, 30(2): 222-7. [Abstract] [Full-text]
10. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
    Clin Cancer Res, 11(7): 2531-9. [Abstract] [Full-text]
11. Ectopic bioactive luteinizing hormone secretion by a pancreatic endocrine tumor, manifested as luteinized granulosa-thecal cell tumor of the ovaries.
    J Clin Endocrinol Metab, 90(4): 2097-103. [Abstract] [Full-text]
12. Early retropancreatic dissection during pancreaticoduodenectomy.
    Am J Surg, 189(4): 488-91. [Abstract] [Full-text]
13. Hypoxia augments gelatinase activity in a variety of adenocarcinomas in vitro.
    J Surg Res, 124(2): 180-6. [Abstract] [Full-text]
14. FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.
    Eur J Nucl Med Mol Imaging, 32(4): 399-404. [Abstract] [Full-text]
15. Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer.
    Eur J Nucl Med Mol Imaging, 32(4): 389-97. [Abstract] [Full-text]
16. Puncture of solid pancreatic tumors guided by endoscopic ultrasonography: a pilot study series comparing Trucut and 19-gauge and 22-gauge aspiration needles.
    Endoscopy, 37(4): 362-6. [Abstract] [Full-text]
17. Significance of histological response to preoperative chemoradiotherapy for pancreatic cancer.
    Ann Surg Oncol, 12(3): 214-21. [Abstract] [Full-text]
18. The prognostic effect of clinical staging in pancreatic adenocarcinoma.
    Ann Surg Oncol, 12(2): 145-51. [Abstract] [Full-text]
19. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
    Ann Surg Oncol, 12(2): 124-32. [Abstract] [Full-text]
20. Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
    Mol Cancer Ther, 4(4): 587-94. [Abstract] [Full-text]
21. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma.
    Int J Cancer, 115(3): 359-67. [Abstract] [Full-text]
22. Nutritional factors and risk of pancreatic cancer: a population-based case-control study based on direct interview in Japan.
    J Gastroenterol, 40(3): 297-301. [Abstract] [Full-text]
23. High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.
    Cancer Res, 65(8): 3218-25. [Abstract] [Full-text]
24. Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases.
    Cancer Res, 65(8): 3092-9. [Abstract] [Full-text]
25. Palliative therapy for pancreatic/biliary cancer.
    Surg Clin North Am, 85(2): 359-71. [Abstract] [Full-text]
26. Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.
    J Clin Oncol, 23(12): 2754-62. [Abstract] [Full-text]
27. Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma: impact on cell motility.
    Clin Cancer Res, 11(8): 2840-52. [Abstract] [Full-text]
28. Induction of endoplasmic reticulum-induced stress genes in Panc-1 pancreatic cancer cells is dependent on Sp proteins.
    J Biol Chem, 280(16): 16508-13. [Abstract] [Full-text]
29. Cancer pattern among hypertensive patients in North Karelia, Finland.
    J Hum Hypertens, 19(5): 373-9. [Abstract] [Full-text]
30. Hematopoietic cytokines in the sera of patients with pancreatic cancer.
    Clin Chem Lab Med, 43(2): 146-50. [Abstract] [Full-text]
31. Carboplatin plus gemcitabine in patients with inoperable or metastatic pancreatic cancer: a phase II multicenter study by the Hellenic Cooperative Oncology Group.
    Ann Oncol, 16(5): 773-9. [Abstract] [Full-text]
32. Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells.
    Br J Cancer, 92(8): 1506-16. [Abstract] [Full-text]
33. Case report: solid-pseudopapillary tumour of the pancreas associated with dorsal agenesis.
    Br J Radiol, 78(929): 441-3. [Abstract] [Full-text]
34. The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation.
    Biochem Biophys Res Commun, 331(1): 295-302. [Abstract] [Full-text]
35. Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer.
    Br J Cancer, 92(8): 1372-81. [Abstract] [Full-text]
36. Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells.
    Carcinogenesis, 26(5): 958-67. [Abstract] [Full-text]
37. mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
    Mol Ther, 11(5): 724-33. [Abstract] [Full-text]
38. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Int J Radiat Oncol Biol Phys, 62(1): 97-103. [Abstract] [Full-text]
39. Mutational analysis of PPARG as a candidate tumour suppressor gene in enteropancreatic endocrine tumours.
    Clin Endocrinol (Oxf), 62(5): 603-6. [Abstract] [Full-text]
40. Human archival tissues provide a valuable source for the analysis of spatial genome organization.
    Histochem Cell Biol, 123(3): 229-38. [Abstract] [Full-text]
41. Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations.
    Pancreatology, 5(1): 67-74. [Abstract] [Full-text]
42. ErbB2 growth factor receptor, a marker for neuroendocrine cells?
    Pancreatology, 5(1): 44-58. [Abstract] [Full-text]
43. A pharmacological study of celecoxib and gemcitabine in patients with advanced pancreatic cancer.
    Cancer Chemother Pharmacol, 55(6): 559-64. [Abstract] [Full-text]
44. Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum.
    Bioinformatics, 21(9): 1764-75. [Abstract] [Full-text]
45. Bootstrap methods for statistical inference from stereological estimates of volume fraction.
    J Microsc, 218: 160-70. [Abstract] [Full-text]
46. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.
    Cancer Genet Cytogenet, 159(1): 10-7. [Abstract] [Full-text]

© 2004-2008 Pancreatic Cancer Research Today. All Rights Reserved.